Abstract
Foxp3 is a specific marker for regulatory T cells (Tregs), and interleukin (IL)-17 is the signature cytokine of T-helper (Th) 17 cells. Recent studies suggested that Foxp3+ Tregs and IL-17+ Th17 cells may be involved in pathogenesis of lichen planus (LP). The objectives of this study were to examine the immunoexpression of Foxp3 and IL-17 in archival paraffin-embedded biopsy specimens from 80 cases of LP (oral LP, n = 42; cutaneous LP, n = 38) and compare against normal control tissues (oral mucosa, n = 10; skin, n = 10). The results showed that the mean number of Foxp3 and IL-17 expression in LP was significantly higher compared to controls, respectively (both P < 0.001). A positive correlation between Foxp3 and IL-17 expression (r = 0.273; P = 0.014) was observed. Moreover, the mean number of Foxp3 expression in oral LP was significantly higher than cutaneous LP (P < 0.001). Collectively, our findings demonstrated the increased expression of Foxp3 and IL-17 in LP lesions including oral and cutaneous variants. Foxp3 expressing in oral LP was higher than cutaneous LP, which may be associated with the difference in clinical behaviour of the two variants of the disease. Further studies are required to investigate the immunopathologic mechanisms and therapeutic target of Foxp3+ Tregs and IL-17+ Th17 cells in LP.
Similar content being viewed by others
References
Abdel-Latif AM, Abuel-Ela HA, El-Shourbagy SH (2009) Increased caspase-3 and altered expression of apoptosis- associated proteins, Bcl-2 and Bax in lichen planus. Clin Exp Dermatol 34:390–395
Baccaglini L, Thongprasom K, Carrozzo M, Bigby M (2013) Urban legends series: lichen planus. Oral Dis 19:128–143
Boyd AS, Neldner KH (1991) Lichen planus. J Am Acad Dermatol 25:593–619
Farhi D, Dupin N (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28:100–108
Hasséus B, Jontell M, Bergenholtz G, Dahlgren UI (2004) Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol 136:483–489
Hu Y, Shen F, Crellin NK, Ouyang W (2011) The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 1217:60–76
Irvine C, Irvine F, Champion RH (1991) Long-term follow-up of lichen planus. Acta Derm Venereol 71:242–244
Lage D, Pimentel VN, Soares TC, Souza EM, Metze K, Cintra ML (2011) Perforin and granzyme B expression in oral and cutaneous lichen planus: a comparative study. J Cutan Pathol 38:973–978
Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG (2012) Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4:22–28
Mai J, Wang H, Yang XF (2010) Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci 15:986–1006
Miyara M, Sakaguchi S (2011) Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89:346–351
Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763–776
Pereira JS, Monteiro BV, Nonaka CF, Silveiraé J, Miguel MC (2012) FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions. Int J Exp Pathol 93:287–294
Piccinni MP, Lombardelli L, Logiodice F et al (2013) Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis. doi:10.1111/odi.12094
Ragaz A, Ackerman AB (1981) Evolution, maturation, and regression of lesions of lichen planus: new observations and correlations of clinical and histologic findings. Am J Dermatopathol 3:5–25
Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus: a review. J Oral Pathol Med 39:729–734
Santoro A, Majorana A, Bardellini E et al (2004) Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol 121:758–764
Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F (2003) NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 201:466–472
Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46:15–21
Shaker O, Hassan AS (2012) Possible role of interleukin-17 in the pathogenesis of lichen planus. Br J Dermatol 166:1367–1368
Tao XA, Li CY, Xia J et al (2009) Differential gene expression profiles of whole lesions from patients with oral lichen planus. J Oral Pathol Med 38:427–433
Tao XA, Xia J, Chen XB et al (2010) FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16:76–82
van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507–512
Vered M, Fürth E, Shalev Y, Dayan D (2013) Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig 17:1365–1373
Wang H, Luo Z, Lei L et al (2013) Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation 36:696–704
Xie S, Ding L, Xiong Z, Zhu S (2012) Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Technol Med Sci 32:451–457
Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462
Acknowledgments
This study was supported by National Natural Science Foundation of China (81200786, 81302358), Science and Technology Commission of Shanghai (13401905700), and Shanghai Natural Science Foundation (12ZR1417000).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Z. Shen and X. Gao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Shen, Z., Gao, X., Ma, L. et al. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res 306, 441–446 (2014). https://doi.org/10.1007/s00403-013-1429-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-013-1429-3